Gardasil gets approval in the EU
Gardasil seems to be Merck's new wunderkind; there's been more press over it than there has been coverage of the tiresome Vioxx lawsuits. Now they've gotten their HPV vaccine approved in the European Union:
Gardasil, the first vaccine to prevent cervical cancer, was endorsed by a panel of European experts on Friday, bringing mass vaccination against the killer disease a step nearer.
[...]
Recommendations for marketing approval by the committee are normally endorsed by the European Commission within a couple of months.
See the Related Posts section for more, in case you've missed all the hot Gardasil action lately. I think once the Vioxx lawsuits are finished, we're going to see Merck do quite well for investors (and the general public) as their pipeline seems a bit more promising than most of their competitors.
[tags]Medicine, pharmacy, Gardasil, Merck, HPV, cancer, oncology[/tags]
No Comments »
No comments yet.
RSS feed for comments on this post.
| TrackBack URI
You can also bookmark
this on del.icio.us or check the cosmos